AMERIPRISE FINANCIAL INC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 131 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$17,928,000
+1160.8%
7,694,417
+1437.1%
0.01%
+700.0%
Q4 2017$1,422,000
+12.6%
500,576
+13.4%
0.00%0.0%
Q3 2017$1,263,000
+33.9%
441,411
+15.6%
0.00%
Q2 2017$943,000
-75.2%
381,782
+57.3%
0.00%
-100.0%
Q4 2015$3,807,000
+64.4%
242,780
+10.5%
0.00%
+100.0%
Q3 2015$2,316,000
-70.1%
219,710
-28.5%
0.00%
-75.0%
Q2 2015$7,750,000
+13.9%
307,263
+25.9%
0.00%0.0%
Q1 2015$6,802,000
+336.6%
244,061
+186.0%
0.00%
+300.0%
Q4 2014$1,558,000
+157.5%
85,348
+82.7%
0.00%
Q3 2014$605,000
-36.2%
46,715
-19.6%
0.00%
-100.0%
Q2 2014$948,000
-84.9%
58,130
-83.7%
0.00%
-75.0%
Q1 2014$6,288,000
-54.7%
355,785
-38.0%
0.00%
-50.0%
Q4 2013$13,895,000
-0.7%
573,933
+45.3%
0.01%
-11.1%
Q3 2013$13,990,000
+1044.8%
394,863
+404.7%
0.01%
+800.0%
Q2 2013$1,222,00078,2360.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2017
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders